Yajin Ni

Title: Yajin Ni: Innovator in Immune Cell Transduction

Introduction

Yajin Ni is a prominent inventor based in San Diego, CA, known for his contributions to the field of immunotherapy. He holds 2 patents that focus on enhancing the efficacy of immune cell therapies, particularly in the context of cancer treatment. His work is pivotal in advancing the capabilities of T cells through innovative methods.

Latest Patents

Yajin Ni's latest patents include "Methods for transducing immune cells" and "Formulations and processes for CAR T cell drug products." The first patent provides improved methods for transducing immune cells, such as T cells, using retroviral vectors to express exogenous gene products, including chimeric antigen receptors (CARs). This patent emphasizes methods that increase transduction efficiency, thereby enhancing the percentage of immune cells expressing the desired gene product. The second patent focuses on formulations and drug product processes that improve cell viability and minimize waste during the manufacturing of formulated cells for drug products.

Career Highlights

Yajin Ni is currently associated with Allogene Therapeutics, Inc., where he applies his expertise in developing innovative therapies. His work is instrumental in pushing the boundaries of what is possible in the realm of cell-based treatments.

Collaborations

Yajin collaborates with notable colleagues, including Muneeswara Babu Medi and Zhuojin Xu, who contribute to the research and development efforts at Allogene Therapeutics, Inc.

Conclusion

Yajin Ni's innovative work in immune cell transduction and CAR T cell therapies positions him as a key figure in the advancement of cancer treatment. His patents reflect a commitment to improving therapeutic outcomes for patients.